Vav3 Modulates B Cell Receptor Responses by Regulating Phosphoinositide 3-Kinase Activation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
To elucidate the mechanism(s) by which Vav3, a new member of the Vav family proteins, participates in B cell antigen receptor (BCR) signaling, we have generated a B cell line deficient in Vav3. Here we report that Vav3 influences phosphoinositide 3-kinase (PI3K) function through Rac1 in that phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation was attenuated by loss of Vav3 or by expression of a dominant negative form of Rac1. The functional interaction between PI3K and Rac1 was also demonstrated by increased PI3K activity in the presence of GTP-bound Rac1. In addition, we show that defects of calcium mobilization and c-Jun NH2-terminal kinase (JNK) activation in Vav3-deficient cells are relieved by deletion of a PIP3 hydrolyzing enzyme, SH2 domain-containing inositol polyphosphate 5′-phosphatase (SHIP). Hence, our results suggest a role for Vav3 in regulating the B cell responses by promoting the sustained production of PIP3 and thereby calcium flux.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Phosphoinositide-specific Phospholipase C Isozymes
Rhee, S. G., & Bae, Y. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15045 · Cited by 876
Fu (1998) · doi:10.1016/s1074-7613(00)80591-9 · Cited by 518
Phospholipase Cγ2 Is Essential in the Functions of B Cell and Several Fc Receptors
Wang, D., Feng, J., Wen, R., Marine, J.-C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L., Murray, P. J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00005-4 · Cited by 475
BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells
Ishiai, M., Kurosaki, M., Pappu, R., Okawa, K., Ronko, I., Fu, C., Shibata, M., Iwamatsu, A., Chan, A. C., & Kurosaki, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80012-6 · Cited by 371
Self-citationActivation of Phospholipase C-γ by Phosphatidylinositol 3,4,5-Trisphosphate
Bae, Y. S., Cantley, L. G., Chen, C.-S., Kim, S.-R., Kwon, K.-S., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4465 · Cited by 366
Wienands, J., Schweikert, J., Wollscheid, B., Jumaa, H., Nielsen, P. J., & Reth, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.791 · Cited by 271 · cited 1×
“In contrast, BLNK and CD19 in B cells may interact with Vav3 and Vav1 with the same efficiency (40, 51, 53, 61, 62).”
BackgroundHashimoto, A., Okada, H., Jiang, A., Kurosaki, M., Greenberg, S., Clark, E. A., & Kurosaki, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1287 · Cited by 199
Self-citationCutting Edge: Essential Role of Phospholipase C-γ2 in B Cell Development and Function
Hashimoto, A., Takeda, K., Inaba, M., Sekimata, M., Kaisho, T., Ikehara, S., Homma, Y., Akira, S., & Kurosaki, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1738 · Cited by 155
Self-citationWatanabe, D., Hashimoto, S., Ishiai, M., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T., & Tsukada, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103675200 · Cited by 136
Self-citation
Cited by
PI3K in lymphocyte development, differentiation and activation
Okkenhaug, K., & Vanhaesebroeck, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1056 · Cited by 810
Role of Bruton’s tyrosine kinase in B cells and malignancies
Pal Singh, S., Dammeijer, F., & Hendriks, R. W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0779-z · Cited by 726
Regulation of B-cell fate by antigen-receptor signals
Niiro, H., & Clark, E. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri955 · Cited by 629
Targeting Bruton's tyrosine kinase in B cell malignancies
Hendriks, R. W., Yuvaraj, S., & Kil, L. P. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3702 · Cited by 552
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392
B Cell Signaling and Fate Decision
Kurosaki, T., Shinohara, H., & Baba, Y. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132541 · Cited by 351
Self-citationP hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 346
Phosphoinositide 3‐kinase‐dependent activation of Rac
Welch, H. C. E., Coadwell, W. J., Stephens, L. R., & Hawkins, P. T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00454-x · Cited by 321
VAV proteins as signal integrators for multi-subunit immune-recognition receptors
Turner, M., & Billadeau, D. D. (2002) · Nature Reviews Immunology · doi:10.1038/nri840 · Cited by 313
Rho family GTPases and their regulators in lymphocytes
Tybulewicz, V. L. J., & Henderson, R. B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2606 · Cited by 272
Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling
Walmsley, M. J., Ooi, S. K. T., Reynolds, L. F., Smith, S. H., Ruf, S., Mathiot, A., Vanes, L., Williams, D. A., Cancro, M. P., & Tybulewicz, V. L. J. (2003) · Science · doi:10.1126/science.1089709 · Cited by 238
Regulation of B-cell signal transduction by adaptor proteins
Kurosaki, T. (2002) · Nature Reviews Immunology · doi:10.1038/nri801 · Cited by 209
Self-citationWeber, M., Treanor, B., Depoil, D., Shinohara, H., Harwood, N. E., Hikida, M., Kurosaki, T., & Batista, F. D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072619 · Cited by 170
Self-citationThe chicken as a model for large-scale analysis of vertebrate gene function
Brown, W. R. A., Hubbard, S. J., Tickle, C., & Wilson, S. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg998 · Cited by 168
Arana, E., Vehlow, A., Harwood, N. E., Vigorito, E., Henderson, R., Turner, M., Tybulewicz, V. L. J., & Batista, F. D. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.003 · Cited by 156
“Previous work has investigated the regulation of Rho GTPases by Vav proteins and PI3K (Crespo et al., 1997; Inabe et al., 2002; Kurosaki, 2002).”
BackgroundOh-hora, M., Johmura, S., Hashimoto, A., Hikida, M., & Kurosaki, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031547 · Cited by 113
“For immunoprecipitation, cells were solubilized in NP-40 lysis buffer supplemented with protease and phosphatase inhibitors as described previously (33), and precleared lysates were incubated with proper Abs and protein A–agarose.”
MethodSelf-citationAiba, Y., Oh-hora, M., Kiyonaka, S., Kimura, Y., Hijikata, A., Mori, Y., & Kurosaki, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407468101 · Cited by 79
Self-citationVedham, V., Phee, H., & Coggeshall, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4211-4220.2005 · Cited by 76
Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.
Lyons, L. S., Rao, S., Balkan, W., Faysal, J., Maiorino, C. A., & Burnstein, K. L. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0158 · Cited by 67
Walliser, C., Retlich, M., Harris, R., Everett, K. L., Josephs, M. B., Vatter, P., Esposito, D., Driscoll, P. C., Katan, M., Gierschik, P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803316200 · Cited by 56
RODRIGUEZ, R., MATSUDA, M., STOREY, A., & KATAN, M. (2003) · Biochemical Journal · doi:10.1042/bj20021778 · Cited by 20
Metadata
- Authors
- Inabe, K., Ishiai, M., Scharenberg, A. M., Freshney, N., Downward, J., & Kurosaki, T.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-01-14
- Volume
- 195
- Issue
- 2
- Pages
- 189-200
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2142977472
- Cited by
- 145
- References
- 9
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.